glp 1 fda compounding Novo asks to prevent compounders from making GLP-1 knockoffs compounding glp-1 fda Targets and

All relevant FDA exclusivity periods for liraglutide have expired, with patent litigation against potential generic competitors starting in 2017

They werent just sipping the Kool-Aid (or should I say, soda?)

The Positive and Negative Effects of GLP-1 Drugs Are Closely Intertwined Warren Yacawych, a neuroscientist at the University of Michigan, and his team tried to disentangle GLP-1 drugs desired effects (reduced food intake and weight loss) from their unwanted accompaniments (often nausea and vomiting)

Weight Loss Was Never Just About Willpower If youve followed me for any amount of time, you already know this: Weight gain is not a willpower problem